A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design

References

• Castle L, Aubert RE, Verbrugge RR, et al. Trends in medication treatment for ADHD. J Atten Disord. 2007;10:335–342.
   PubMedGoogle Scholar
• McGough JJ. Treatment controversies in adult ADHD. Am J Psychiatry. 2016;173:960–966.
   PubMed Web of Science ®Google Scholar
• Glenngard AH, Hjelmgren J, Thomsen PH, et al. Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway. Nord J Psychiatry. 2013;67:351–359.
   PubMed Web of Science ®Google Scholar
• Brams M, Moon E, Pucci M, et al. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day. Curr Med Res Opin. 2010;26:1809–1825.
   PubMed Web of Science ®Google Scholar
• Thomas M, Rostain A, Prevatt F. ADHD diagnosis and treatment in college students and young adults. Adolesc Med State Art Rev. 2013;24:659–679.
   PubMedGoogle Scholar
• Jain R, Katic A. Current and investigational medication delivery systems for treating attention-deficit/hyperactivity disorder. Prim Care Companion CNS Disord. 2016;18(4). doi:10.4088/PCC.16r01979.
   Google Scholar
• Setyawan J, Hodgkins P, Guerin A, et al. Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis. J Med Econ. 2013;16:962–975.
   PubMedGoogle Scholar
• Hodgkins P, Sasané R, Christensen L, et al. Persistence, augmentation, and consumption of long-acting medications in ADHD patients. Am J Pharm Benefits. 2012;4:e149–e158.
   Google Scholar
• Frick G, Yan B, Adler LA. Triple-bead mixed amphetamine salts (SHP465) in adults with ADHD: results of a phase 3, double-blind, randomized, forced-dose trial. J Atten Disord. 2017. e-publication ahead of print. DOI:10.1177/1087054717696771.
   Web of Science ®Google Scholar
• Spencer TJ, Adler LA, Weisler RH, et al. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry. 2008;69:1437–1448.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Greenbaum M, Arnold V, et al. Efficacy and safety of SHP465 mixed amphetamine salts in the treatment of attention-deficit/hyperactivity disorder in adults: results of a randomized, double-blind, placebo-controlled, forced-dose clinical study. CNS Drugs. 2017;31:685–697.
   PubMed Web of Science ®Google Scholar
• Adler LA, Frick G, Yan B. A long-term, open-label, safety study of triple-bead mixed amphetamine salts (SHP465) in adults with ADHD. J Atten Disord. 2017. e-publication ahead of print. DOI:10.1177/1087054717696770.
   Web of Science ®Google Scholar
• Wigal T, Brams M, Gasior M, et al. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behav Brain Funct. 2010;6:34.
   PubMed Web of Science ®Google Scholar
• Wigal SB, Wigal TL. The laboratory school protocol: its origin, use, and new applications. J Atten Disord. 2006;10:92–111.
   PubMedGoogle Scholar
• Cassuto H, Ben-Simon A, Berger I. Using environmental distractors in the diagnosis of ADHD. Front Hum Neurosci. 2013;7:1–10.
   PubMed Web of Science ®Google Scholar
• Riccio CA, Waldrop JJ, Reynolds CR, et al. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci. 2001;13:326–335.
   PubMed Web of Science ®Google Scholar
• McGee RA, Clark SE, Symons DK. Does the Conners’ continuous performance test aid in ADHD diagnosis? J Abnorm Child Psychol. 2000;28:415–424.
   PubMed Web of Science ®Google Scholar
• Bedard AC, Stein MA, Halperin JM, et al. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder. J Child Psychol Psychiatry. 2015;56:40–48.
   PubMed Web of Science ®Google Scholar
• McCracken JT, Biederman J, Greenhill LL, et al. Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42:673–683.
   PubMed Web of Science ®Google Scholar
• Swanson JM, Wigal S, Greenhill LL, et al. Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry. 1998;37:519–526.
   PubMed Web of Science ®Google Scholar
• Dopfner M, Gerber WD, Banaschewski T, et al. Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting. Eur Child Adolesc Psychiatry. 2004;13:i93–101.
   PubMed Web of Science ®Google Scholar
• Biederman J, Boellner SW, Childress A, et al. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study. Biol Psychiatry. 2007;62:970–976.
   PubMed Web of Science ®Google Scholar
• Wigal SB, Wigal T, Childress A, et al. The time course of effect of multilayer-release methylphenidate hydrochloride capsules: a randomized, double-blind study of adults with ADHD in a simulated adult workplace environment. J Atten Disord. 2016. e-publication ahead of print. DOI:10.1177/1087054716672335.
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79:373–374.
   PubMed Web of Science ®Google Scholar
• First M, Spitzer R, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version. Arlington, VA: American Psychiatric Publishing; 1997.
   Google Scholar
• Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
   PubMed Web of Science ®Google Scholar
• Backhaus J, Junghanns K, Broocks A, et al. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002;53:737–740.
   PubMed Web of Science ®Google Scholar
• DuPaul GJ, Power TJ, Anastopoulos AD, et al. ADHD Rating Scale-IV: checklists, norms, and clinical interpretation. New York, NY: Guilford Press; 1998.
   Google Scholar
• Wigal T, Childress A, Frick G, et al. Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment. Postgrad Med. 2018;130:111–121.
   PubMed Web of Science ®Google Scholar
• Manor I, Vurembrandt N, Rozen S, et al. Low self-awareness of ADHD in adults using a self-report screening questionnaire. Eur Psychiatry. 2012;27:314–320.
   PubMed Web of Science ®Google Scholar
• Knouse LE, Bagwell CL, Barkley RA, et al. Accuracy of self-evaluation in adults with ADHD: evidence from a driving study. J Atten Disord. 2005;8:221–234.
   PubMedGoogle Scholar
• Hoza B, Gerdes AC, Hinshaw SP, et al. Self-perceptions of competence in children with ADHD and comparison children. J Consult Clin Psychol. 2004;72:382–391.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Biederman J, Spencer TJ, et al. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006;11:625–639.
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001;58:775–782.
   PubMed Web of Science ®Google Scholar